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1. Introduction 
The formation of the C3 convertase of the classical 
pathway in the complement cascade involves peptides 
C2a and C4b generated by the proteolysis of C2 and 
c4 by CT [l]. 
The purification and the structural characteristics 
of C4 [2-41 and the binding properties of C4b to 
membranes and immune complexes have been 
described [ 5,6]. The binding of C4b to immuno- 
globulins has also been demonstrated [7]. Since most, 
if not all, C4 purification protocols lead to C4 con- 
taining contaminating traces of C4-binding protein 
(C4bp) [8], we have worked out a technique which 
allows the purification of C4 free from any trace of 
C4bp. 
With the view of studying the cleavage of C4 by 
Cis we labelled C4 with 1251. The distribution of the 
label in C4 depends on the labelling conditions used; 
it reflects a clear-cut difference between C4 and C4b 
structures and points to a relatively masked position 
of the N-terminal portion of the ~11 chain in C4 and 
of C4a in Cis cleaved C4. The interaction between C4 
and Cis in the presence and in the absence of calcium 
is discussed. 
Abbreviations: SDS-PAGE, sodium dodecyl sulphate-poly- 
acrylamide gel electrophoresis; EDTA, ethylene diamine 
tetracetic acid; DFP, diisopropylphosphorofluoridate; PEG, 
polyethylene glycol; STI, soybean trypsin inhibitor 
The nomenclature of the components of complement is that 
recommended by World Health Organization (I 968). A ba.r 
indicates the activated state of a component 
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2. Materials and methods 
Human titrated plasma was obtained from the 
Centre de Transfusion Sanguine (Grenoble). Cis was 
purified as in [9]. 
Protein estimation during C4 purification was by a 
modified Folin reaction, using bovine serum albumin 
as a reference [ 121. C4 was selectively estimated by 
radial immunodiffusion. Double immunodiffusion in 
agarose was used for qualitative identification of 
protein. 
Sucrose gradient centrifugation was done as in 
[ 131. SDS-PAGE of proteins was as in [9]. 
C4-deficient human serum was kindly provided by 
Dr G. Hauptmann (Strasbourg). Antibodies against 
this serum were raised in rabbits using 0.5 ml serum 
with complete Freund adjuvant and 0.125 ml for the 
boost injection, essentially according to [IO]. The 
total immunoglobulin fraction of the antisera was 
precipitated with sodium sulphate and the resulting 
protein coupled to Sepharose 6B as in [9]. 
C4 functional assay was by a one-step method using 
CCdeficient guinea pig serum, according to [ 111; the 
strain of C4-deficient guinea pigs was a generous gift 
from Dr P. Lachmann (Cambridge). 
The proteolysis of C4 by Cis was carried out by 
incubation for 30 min at 37% of the two proteins in 
a 20: 1 w/w ratio. To detect C4a, the total incubation 
medium was submitted to SDS-PAGE and Coomassie 
blue staining. 
“‘1 labelling of proteins was by two methods, that 
of Bolton and Hunter [ 141 and with lactoperoxidase 
(LPO), which was a modification of the technique of 
ElsevierlNorth-Holland Biomedical Press 
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Heusser et al. [15]: to 1 mg of protein dissolved in 
1 ml 100 mM Tris-HCl, 150 mM NaCI, 5 mM EDTA 
and 5 mM DFP (pH 7.4) the following were added 
successively: 50 ~120 PM KI, 50 ~1 Na’251 (spec. 
act. 1 @i/& 50 ~1 1 mg/ml lactoperoxidase (Cal- 
biochem grade A) and finally 40 ~1 H202 (dilution 
l/6000) in 4 equal aliquots at times 0,3,6 and 9 min 
of incubation at 37’C. After a further 16 min incuba- 
tion the reaction was stopped with 20 ~1 NaN3 
(20% solution, w/v). Free iodine was eliminated by 
dialysis against 100 mM Tris-HCl, 150 mM NaCl, 
5 mM EDTA, (pH 7.4). “‘1 was measured with a 
CG 2000 Intertechnique Counter on the different 
solutions or on 2 mm gel slices after SDS-PAGE of 
the labelled proteins. The average radioactive iodine 
binding was between 0.03 and 0.1 mol 12sI/mol C4. 
Fluorescence measurements were made with a 
MPF2A Perkin Elmer Spectrofluorimeter using the 
classical tryptophan excitation and fluorescence 
spectra. 
3. Results 
3.1. Purification of C4 
3 .l .l . Treatment of plasma by inhibitors 
Frozen plasma was thawed and incubated for 
40 min at 20°C in 5 mM DFP, 5 mM EDTA, 2.7 mM 
iodoacetamide, 10 pg/ml heparin and 25 I.cg/ml STI. 
At the end of the incubation the pH was adjusted to 
7.4 with NaOH. 
3 .1.2. PEG precipitation 
PEG 4000 was dissolved in 100 mM phosphate 
buffer (pH 7.4) containing 150 mM NaCl, 15 mM 
EDTA, 5 mM DFP, 500pg/ml iodoacetamide, lOgg/ml 
heparin and 25 pg/ml STI. All subsequent operations 
were performed at 4°C. PEG 15% (w/v) was added to 
300 ml plasma to 5% (w/v) final cont., after 30 min 
the medium was centrifuged for 20 min at 5000 X g. 
PEG 26% (w/v) was added to the supernatant to 12% 
final cont.; after 30 min incubation, the resulting 
precipitate was collected by centrifugation for 20 min 
at 7000 X g. The pellet was redissolved in 80 ml 
20 mM phosphate buffer (pH 7.4) with 5 mM EDTA, 
5 p/ml STI, 5 mM DFP and incubated for 16 h. 
3.1.3. DEAE cellulose steps 
The PEG extract was diluted to a conductivity of 
2.9 mS and applied to a column of DE-52 cellulose 
(1.6 X 6 cm) equilibrated in 20 mM phosphate buffer 
(pH 7.0) containing 10 mM NaCl, 5 mM EDTA and’ 
5 pg/ml STI. The column was eluted with the same 
buffer until the eluateA2so was< 0.4. C4 was detected 
in the eluate by double immunodiffusion and pooled 
for the next step. A second DE-52 cellulose column 
(2.8 X 5.5 cm) was prepared in 20 mM phosphate 
buffer (pH 7.0) with 30 mM NaCl, 5 mM EDTA and 
5 pg/ml STI. DFP (5 mM) was added to the pooled 
eluate from the first column before the second 
chromatography. After application of the fraction 
the column was washed with the equilibration buffer 
until the eluate Azsc was < 0.1. Elution was carried out 
with a linear gradient of 30-200 mM NaCl in 5 mM 
EDTA, 20 mM phosphate (pH 7.0) (total vol. 360 ml). 
C4 was detected in the eluate by double immuno- 
diffusion and pooled in the presence of 5 mM DFP. 
After concentration by ultrafiltration on PM10 
Table 1 
C4 purification 
Step Total protein C4 antigena Yield in C4 Spec. act.a Purification factor 
(mg) (mg) antigen % (CH SO/mg prot. units C4) 
Protein Spec. act. 
Plasma 16 500 96.0 100 0.98 lo4 1.0 1.0 
S- 12%, PEG precipitate 7178 79.2 82.5 0.86 lo4 1.9 0.9 
1 st DEAE eluate 3330 33.3 34.7 1.29 10’ 1.7 1.3 
2nd DEAE eluate after 33 19.7 20.5 1.04 10‘ 103.0 106.0 
concentration 
Affinity column eluate after 15 13.8 14.0 4.70 10‘ 158.0 479.5 
concentration 
a Total protein, antigenic and functional C4 were determined as in section 2 
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(Amicon) the pool was dialyzed against 100 mM step, which underlines the efficiency of the affinity 
Tris-HCl , 150 mM NaCl and 5 mM EDTA (pH 7.4). column. 
3 .1.4. Affinity chromatography on Sepharose-bound 
antibodies to C4-deficient serum 
Immunoadsorbent (30 ml) was equilibrated in the 
buffer used for the preceding dialysis step. The 
dialyzed fraction was put onto the column which was 
then washed with the equilibration buffer. C4 was 
eluted slightly after the void volume due to its non- 
specific interaction with the activated Sepharose 
matrix. The fractions containing C4 were pooled and 
concentrated on PM10 in the presence of 5 mM DFP. 
The purity of the purified C4 was checked by 
SDS-PAGE. As shown in fig.1, C4 appears as a 
monoband protein prior to reduction and exhibits the 
three characteristic (Y, fl and y chains after reduction 
and alkylation, in a 0.56 : 0.82 : 1 molar ratio, 
calculated from scanning at 550 nm and app. mol. 
wt 31000,70 000 and 87 500. 
A typical purification run is presented in table 1. 
The final yield of C4 approaches 15% with a purifica- 
tion factor of - 160 on a protein basis and 480 on 
a specific activity basis. The difference between these 
two values becomes apparent at the last purification 
The control by double immunodiffusion in agarose 
was negative with the following antisera to: C4- 
deficient serum, C4-binding protein, prepared in the 
1aboratory;P 11 S protein (gift from Dr R. M. Chapuis, 
Dr Isliker, Lausanne); C3, IgG, IgM, transferrin, 
albumin, ceruloplasmin, plasminogen, Cir , C 1 t, CiIn, 
Cis and C5; with antiserum to whole serum only 1 
precitin line was detected. 
Fig.1. SDS-PAGE of C4. Electrophoresis was carried out as 
described in section 2. - 35 pg protein were applied to each 
gel. (1) Unreduced C4; (2) Reduced and alkylated C4. 
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3.2. Iodination of C4 and of Cis-treated C4 
Iodination by ‘?‘I was used to evaluate the struc- 
tural changes resulting from splitting, of C4 by Cis. 
The two different techniques described in section 2 
were used concurrently and led to different labelling 
of C4. In C4 the LPO technique as shown in fig.2 
preferentially labelled the y chain; the (Y chain was 
also efficiently labelled. In contrast, the Bolton and 
Hunter technique (fig.3) led to the predominant 
labelling of the P chain, and very low radioactivity in 
the (Y chain. 
With C4 incubated with Cis in EDTA, the Bolton 
and Hunter technique gave approximately the same 
- + 
GEL LENGTH (cm) 
Fig. 2. Distribution of radioactivity in C4 chains (LPO tech- 
nique). Reduced and alkylated sample. Electrophoresis and 
counting were as described in section 2. 
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Fig. 3. Distribution of radioactivity in C4 chains (Bolton and 
Hunter technique). Reduced and alkylated sample was loaded 
onto the gel. Electrophoresis and counting were as described 
in section 2. 
pattern of radioactivity for C4b chains as for C4 
chains. 
In contrast the LPO technique, as shown in fig. 4, 
led to a relative increase in the labelling of the y chain 
and an inverted radioactivity a’/p’in C4b compared 
with the o/P ratio in C4. When the LPO labelling was 
performed after incubation of C4 in 6 M urea, 
followed by dialysis to remove the urea, the ‘?‘I 
distribution largely paralleled that of C4b. This 
+ cleaved C4 
0 2 4 6 8 10 
GEL LENGTH (cm) 
Fig. 4. Distribution of radioactivity in Cis cleaved C4 chains 
(LPO technique). After cleavage of C4 by Cis and direct 
iodination of the mixture as described in section 2 a reduced 
and alkylated aliquot of the incubation medium was loaded 
onto the gel. Electrophoresis and counting were as described 
in section 2. 
observation, together with the above evidence for a 
conformational difference between C4 and C4b 
reflected by the “‘1 distribution in the chains, is 
reinforced by the observation that this urea-treated 
C4 is no longer a substrate for Cis. 
3.3. 12’1 labelling of C4a 
It must be emphasized that by both techniques 
there is neither evidence of “‘1 labelling of the 
N-terminal end of the (Y chain of C4 nor of the 
corresponding C4a peptide in Cis-treated C4. However 
this peptide is easily detected on SDS gels by 
Coomassie blue staining. 
The labelling of C4a was achieved using two dif- 
ferent sets of conditions: 
(0 
(ii) 
The incubation mixture C4 t Cis was treated 
with 6 M urea after the proteolysis of C4 arid 
iodinated by the Bolton and Hunter technique: a 
radioactive peptide was detected on SDS-PAGE 
showing an app. mol. wt 10 700 and 20 500, 
respectively, after and before reduction, and 
coinciding with the C4a band revealed by 
Coomassie blue staining. 
In more recent experiments, C4 was proteolysed 
by Cis in the presence of 5 mM calcium and 
directly labelled by the Bolton and Hunter 
technique without urea treatment. In this case 
12SI-labelled C4a was detected on SDS-PAGE. 
3.4. Sucrose gradient centtifigation of C4 and Cis- 
When ‘251-labelled C4 was centrifuged in a sucrose 
gradient (figSa) a major 7.2 S peak was observed. In 
contrast (figSb) the centrifugation of r251-labelled C4 
cleaved by Cis showed in addition to the 7.2 S peak 
a 10.4 S peak. There was no evidence for the presence 
of labelled C4a. There was no increase in 10.4 S pro- 
teins when different amounts of C4 were added to 
C4b which indicated that cleavage of C4 by Cls was 
necessary for dimer formation. Analysis of these peaks 
of Cis-cleaved C4 on SDS-PAGE confirmed the 
formation of dimers of C4b by the presence of high 
molecular weight bands in the 10.4 S peak (fig.6B) 
whereas a conventional pattern of C4b was found for 
the 7.2 S peak (fig.6A). This tendency of C4b to 
associate spontaneously confirms other observations 
on the aggregation ability of the (Y’ chain of C4 [2] 
and may account for the reactivity of C4b. 
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i 
TUBE N” TUBE NQ 
Fig.5. Sucrose gradient ultracentrifugation of C4 and Cis 
cleaved C4. S-20% sucrose gradients in buffer (0.1 M Tris- 
HCl, 0.15 M NaCl, 5 mM EDTA (pH 7.4) or 0.1 M Tris-HCl, 
0.15 M NaCl, 1 mM MgCI, ,0.3 mM CaCl, (pH 7.4) were run 
at 34 000 rev./min at 3°C for 15 h in a TST 54 rotor 
(Kontron). Standard proteins indicated by the arrows were 
centrifuged in parallel; the reference values chosen were: (1) 
alcohol dehydrogenase, 7.6 S; (2) Catalase, 11.4 S; (3) apo- 
ferritin, 17.6 S [9]. (a) C4; (b) Cis-cleaved C4. 
4. Discussion 
It appears necessary to eliminate any trace of 
C4bp in C4 preparations to be used for biological 
activity studies, as C4bp in the fluid phase may com- 
pete with the membranes for C4b binding [ 161. 
Reverse immune affinity with anti-C4-deficient serum 
immunoglobulin coupled to Sepharose appears to us 
the most suitable means of purification, as it combines 
the specific immune affinity and the less specific 
interaction of C4 with the activated Sepharose matrix. 
A difference of conformation between C4 and C4b 
from differences in electrophoretic mobility and 
sedimentation behaviour has been discussed [ 171. The 
different 12’ I labelling patterns of C4 and C4b reported 
here point also to a difference in conformation 
between C4 and C4b. This has been observed only 
with the LPO technique and it seems that other, more 
drastic iodination procedures are less suitable. These 
results can be paralleled with a decrease in the intrinsic 
fluorescence of C4 after splitting by Cis. The 
aggregation ability of C4b confirms the observation 
[7] and may be an important factor in the orientation 
of C4b in the complement cascade. From the labelling 
of urea-treated C4, it can be envisaged that the o,fl 
and y chain of C4 are likely to assume two different 
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Fig.6. SDS-PAGE analysis of sedimentation peaks of Cis 
cleaved C4. Electrophoresis and counting was as described 
in section 2. (-) Reduced and alkylated samples; (---) 
unreduced samples. 
(a) samples corresponding to tube 8 of fig.Sb. 
(b) samples corresponding to tube 12 of fii.5b. 
conformations, one corresponding to native C4 and 
one to a proteolysed C4 conformation. This is con- _ 
firmed by observations that C4 after freezing at -20°C 
lacked haemolytic activity; the labelling pattern of 
this C4 was similar to that of the urea-treated C4. In 
both cases no proteolysis of the cr chain was detectable 
in C4 by SDS-PAGE. 
C4a was found to be difficult to label, which is in 
agreement with [ 171 and in contrast to [ 181. This 
cannot be due to a deficit in its tyrosine or lysine 
contents as compared with the rest of the C4 molecule 
[ 171. It appears that the N-terminal end of the cr 
chain is relatively buried in C4, which may also 
explain that the separation of C4a from C4b requires 
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either incubation at acid pH [4,17,18] or treatment 
with urea and SDS at the concentration used for 
SDS-PAGE. The accessibility of C4a is increased by 
urea treatment of the EDTA Cis-cleaved C4 and also 
by proteolysis of C4 by Cis in the presence of cal- 
cium: in the latter case Cis dimerizes and the Cis 
dimer-C4 interaction is sufficient o expose or release 
C4a available for *25 I binding. The role of C4a in the 
C3 convertase formation is presently under investiga- 
tion. 
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